The NIH awarded up to $130 million over seven years for UGA to develop universal flu vaccine
On Sept. 30, 2019, the University of Georgia (UGA) announced it had signed a contract with the National…
-
-
DARPA funded a $21.9 gene modulation research initiative at Georgia Tech, targeting influenza pandemics
In Jun. 2019, Defense Advanced Research Projects Agency (DARPA) announced it had funded a $21.9 gene modulation research…
-
Vaccitech universal flu vaccine passed Phase 2b clinical development milestones
On Jun. 5, 2019, Vaccitech announced that it has administered its pandemic universal influenza A vaccine MVA-NP+M1 (VTP-100)…
-
FDA approved use of the 05 mL dose of Sanofi’s Fluzone Quadrivalent influenza vaccine to include children age 6 through 35 months
On Jan. 23, 2019, U.S. Food and Drug Administration (FDA) announced it had approved approved the use of…
-
CDC published ACIP’s 2018-19 influenza vaccination recommendations
On Aug. 24, 2018, the Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee’s (ACIP)…
-
CDC published ACIP’s recommendations for use of quadrivalent live attenuated influenza vaccine (LAIV4) in 2018-19 influenza season
On Jun. 8, 2018, the U.S. Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee…
-
Biotechnology | Influenza | Therapeutics | Vaccine | WHO
Medigen Vaccines and GC Pharma collaborated to commercialize quadrivalent influenza vaccine in Taiwan
On Apr. 23, 2018, Medigen Vaccine Biologics and GC Pharma entered an exclusive distribution agreement for GCC’s quadrivalent…
-
The American College of Obstetricians and Gynecologists released opinion on influenza vaccination in pregnancy
On Apr. 1, 2018, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices and the…
-
FDA approved expanded pediatric age indication for Fluarix Quadrivalent influenza vaccine
On Jan. 11, 2018, the U.S. Food and Drug Administration (FDA) approved an expanded indication for the four-strain…
-
Biotechnology | CDC | Influenza | Vaccine
CDC published ACIP 2017-18 influenza vaccination recommendations
On Aug. 25, 2017, the U.S. Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee…
-
Biotechnology | CDC | Influenza | Non-Profit Research | Radiology | Stem Cell | Vaccine
CDC published ACIP recommendations for prevention and control ofﾠ Haemophilus influenzaeﾠ type b (Hib) ﾠdisease
On Feb. 28, 2014, the U.S. Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee…
-
Biotechnology | FDA | Influenza | Vaccine
FDA approved quadrivalent formulation of Fluarix
On Dec. 14, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved GlaxoSmithKline’s quadrivalent formulation…
-
A milestone in protection from influenza was reached with FDA approval for Novartis to manufacture seasonal influenza vaccine using cell-based technology in a US facility
On Nov. 20, 2012, the FDA approved a seasonal flu vaccine produced by Novartis using animal cell culture…
-
Biotechnology | FDA | Influenza | Vaccine
FDA approved first seasonal influenza vaccine manufactured using cell culture technology
On Nov. 20, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved first seasonal influenza…
-
WHO declared end to 2009 H1N1 influenza pandemic
On Aug. 10, 2010, WHO Director-General Dr Margaret Chan announced that the H1N1 influenza virus had moved into…
-
ACIP recommended universal Influenza vaccination for those 6 months of age and older
On Feb. 24, 2010, the Immunization Practices Advisory Committee (ACIP) recommended universal Influenza vaccination for those 6 months…
-
FDA approved high-dose inactivated influenza vaccine for people ages 65 years and older
On Dec. 23, 2009, the FDA approved high-dose inactivated influenza vaccine (Fluzone High-Dose) for people ages 65 years…
-
swine flu outbreak declared a national emergency
On Oct. 24, 2009, President Barack Obama declared the swine flu (N1n1) outbreak a national emergency. The declaration…
-
ACIP issued recommendations on the use of H1N1 influenza vaccines
On Jul. 31, 2009, the Immunization Practices Advisory Committee (ACIP) updates the 2008 recommendations regarding the use of…
-
WHO declared world at the start of 2009 influenza pandemic
On Jun. 11, 2009, the Dr. Margaret Chan, Director-General World Health Organization (WHO), declared the world was at…
-
HHS directed $1 billion toward development of vaccine for novel influenza A (H1N1)
On May 22, 2009, the U.S. Dept. of Health and Human Services (HHS) directed $1 billion toward development…
-
The CDC identified the novel H1N1 influenza virus
On Apr. 15, 2009, the U.S. Centers for Disease Control and Prevention (CDC) identified the novel H1N1 influenza…
-
Physicians used point of care rapid immunoassay tests to provide influenza results during H1N1 pandemic
In Apr. 2009, physicians used point of care rapid immunoassay tests to provide influenza results within 15 minutes…
-
An increased risk of narcolepsy was found following vaccination with Pandemrix
In 2009, an increased risk of narcolepsy (a chronic sleep disorder) was found following vaccination with Pandemrix, a…
-
Biotechnology | FDA | Polio | Vaccine
FDA licensed Sanofi Pasteur’s new pediatric combination vaccine, Pentacel
On Jun. 23, 2008, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had licensed Pentacel, Diphtheria…
-
ACIP voted to expand influenza recommendation to include vaccination for children ages 6 months-18 years
On Feb. 27, 2008, the Immunization Practices Advisory Committee (Immunization Practices Advisory Committee (ACIP) voted to expand influenza…
-
The CDC received FDA approval for a highly sensitive influenza PCR assay
In 2008, the U.S. Centers for Disease Control and Prevention (CDC) received U.S. Food and Drug Administration (FDA)…
-
CDC | Diagnostics | Influenza | Therapeutics
The Influenza Reagent Resource was established by the CDC
In 2008, the Influenza Reagent Resource (IRR) was established by the Centers for Disease Control and Prevention (CDC)…
-
FDA approved use of FluMist nasal-spray influenza vaccine in children age 2-5 years
On Sept. 20, 2007, the U.S. Food and Drug Administration (FDA) approved use of FluMist nasal-spray influenza vaccine…
-
Biotechnology | COVID-19 | Diagnostics | Disease | Influenza | Plague | Therapeutics | Vaccine
Fort Knox prepared for pandemic outbreak scenarios
On Jun. 7, 2007, years before the COVID-19 pandemic swept across the globe, a group of about 100…
